Elite Pharmaceuticals Inc (ELTP)

[namtae]

That would be true if not for the fact its 100% FOS!!

SO in ESSENCE Elite NOW has the possibility to have the FIRST & ONLY:

1) ADT IR opioid with AD label

2) generic ADT opioid with AD label.

There is no possibility with a REJECTED, UNSAFE DRUG!

All ADF IR opioid developers already understand Sequest cannot overcome the Tmax delay!! The only solution being constantly put forth is labeling!!

BUT...we all know the FDA stated in spades that labeling will not mitigate the risk of OVER DOSING

Game, set, match!!